Reply to the letter to the editor 'Second-line chemotherapy in advanced biliary cancer: the present now will later be past' by Vivaldi et al.

被引：1
|
作者：
Lamarca, A. [1 ]
Hubner, R. A. [1 ]
Ryder, W. D. [2 ]
Valle, J. W. [1 ]
机构：
[1] Acad Hlth Sci Ctr, Dept Med Oncol, Manchester, Lancs, England
[2] Christie NHS Fdn Trust, MAHSC Clin Trials Unit, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷 / 12期
关键词：
D O I：
10.1093/annonc/mdu382
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2444 / 2446
页数：3
相关论文
共 50 条
  • [31] Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
    Rizzo, Alessandro
    Salati, Massimiliano
    Frega, Giorgio
    Merz, Valeria
    Caputo, Francesco
    Di Federico, Alessandro
    Palloni, Andrea
    Carloni, Riccardo
    Ricci, Angela Dalia
    Gadaleta-Caldarola, Gennaro
    Messina, Carlo
    Spallanzani, Andrea
    Gelsomino, Fabio
    Benatti, Stefania
    Luppi, Gabriele
    Melisi, Davide
    Dominici, Massimo
    Brandi, Giovanni
    [J]. MEDICINA-LITHUANIA, 2022, 58 (11):
  • [32] Analysis of efficacy and prognostic factors for second-line chemotherapy in gemcitabine-refractory advanced biliary tract cancer
    Okano, N.
    Kawai, K.
    Kobayashi, T.
    Naruge, D.
    Nagashima, F.
    Furuse, J.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [33] Second-line fluoropyrimidine-based doublet chemotherapy for advanced biliary tract cancer: a new standard of care?
    Rizzo, Alessandro
    Cusmai, Antonio
    Palmiotti, Gennaro
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (03) : 201 - 203
  • [34] Reply to the letter to the editor 'Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al.
    Gillessen, S.
    Fanti, S.
    Omlin, A.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (11) : 2354 - 2355
  • [35] Reply to the letter to the editor 'Insertion of central venous catheters (CVCs): any changes in the past ten years' by Biffi et al.
    Pinto, D.
    Gouveia, P.
    Sousa, B.
    Hutka, M.
    Furlanetto, J.
    Mariz, J. M.
    Wuerstlein, R.
    Cardoso, F.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (07) : 1351 - 1352
  • [36] Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Saito, Kei
    Oyama, Hiroki
    Kanai, Sachiko
    Suzuki, Tatsunori
    Sato, Tatsuya
    Hakuta, Ryunosuke
    Ishigaki, Kazunaga
    Takeda, Tsuyoshi
    Saito, Tomotaka
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) : 1093 - 1102
  • [37] FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy
    Roussot, Nicolas
    Vincent, Julie
    Palmier, Remi
    Constantin, Guillaume
    Bengrine, Leila
    Fumet, Jean-David
    Ghiringhelli, Francois
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases
    Naminatsu Takahara
    Yousuke Nakai
    Hiroyuki Isayama
    Takashi Sasaki
    Kei Saito
    Hiroki Oyama
    Sachiko Kanai
    Tatsunori Suzuki
    Tatsuya Sato
    Ryunosuke Hakuta
    Kazunaga Ishigaki
    Tsuyoshi Takeda
    Tomotaka Saito
    Suguru Mizuno
    Hirofumi Kogure
    Minoru Tada
    Kazuhiko Koike
    [J]. Investigational New Drugs, 2018, 36 : 1093 - 1102
  • [39] SECOND-LINE CHEMOTHERAPY WITH S-1 AFTER CISPLATIN AND GEMCITABINE FAILURE IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Ueda, Shinya
    Kawakami, Hisato
    Okamoto, Wataru
    Nishina, Shinichi
    Kudo, Toshihiro
    Makimura, Chihiro
    Kiyota, Hidemi
    Tanaka, Kaoru
    Kaneda, Hiroyasu
    Fujisaka, Yasuhito
    Miyazaki, Masaki
    Turutani, Junji
    Okamoto, Isamu
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 65 - 65
  • [40] In reply to letter to the editor by Dr Willems et al. re: Eccles et al. Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations
    Eccles, Cynthia
    Haider, Masoom A.
    Dawson, Laura A.
    [J]. ACTA ONCOLOGICA, 2010, 49 (02) : 256 - 257
12345